1981
DOI: 10.1038/289176a0
|View full text |Cite
|
Sign up to set email alerts
|

Fluoromevalonate acts as an inhibitor of insect juvenile hormone biosynthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
41
0

Year Published

1982
1982
2009
2009

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 102 publications
(44 citation statements)
references
References 10 publications
1
41
0
Order By: Relevance
“…114) Kuwano and coworkers discovered several 1,5-disubstituted imidazole derivatives with anti-JH activity to the silkworm Bombyx mori. 115,116) The most active compounds are KK-22, KK-42 and KK-98.…”
Section: Inhibitors Of Biosynthetic Enzymesmentioning
confidence: 99%
“…114) Kuwano and coworkers discovered several 1,5-disubstituted imidazole derivatives with anti-JH activity to the silkworm Bombyx mori. 115,116) The most active compounds are KK-22, KK-42 and KK-98.…”
Section: Inhibitors Of Biosynthetic Enzymesmentioning
confidence: 99%
“…The evidence for potential HMG CoA reductase regulation of JH synthesis has been derived from characterization of isolated corpora allata, the principal site of JH synthesis, of the tobacco hornworm. These studies have shown that JH synthesis can be blocked by mevalonate analogs (37) and competitive inhibitors of HMG CoA reductase (33) but is stimulated 100-fold by the addition of a key JH intermediate derived from mevalonate, farnesenic acid (45). Although the tobacco hornworm evidence suggests that the availability of mevalonate is essential for JH synthesis, studies in the cockroach corpora allata suggest that HMG CoA reductase may not be rate limiting for JH synthesis (18).…”
mentioning
confidence: 99%
“…For example, inhibition of mevalonate kinase may provide an alternative means to statin drugs for the regulation of cholesterol synthesis 1,[15][16][17] and as insecticides which target juvenile hormone biosynthesis 18 . There is also interest in inhibiting bacterial GHMP kinases for the development of novel antibiotics 19 , and galactokinase inhibition has been proposed as a therapy for type I galactosemia 20 .…”
mentioning
confidence: 99%